Neuropace Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Neuropace, Inc. on June 17, 2022, regarding events occurring on June 13, 2022. The filing details the results of the company's 2022 Annual Meeting of Stockholders, which was conducted virtually via live webcast.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
Two proposals were submitted to stockholders at the Annual Meeting:
- Proposal 1: Election of Directors. Stockholders elected Class I director nominees Michael Favet and Frank Fischer to serve until the 2025 Annual Meeting.
- Michael Favet: 14,886,315 votes For; 1,376,600 votes Withhold; 6,497,979 Broker Non-Votes.
- Frank Fischer: 14,476,168 votes For; 1,786,747 votes Withhold; 6,497,979 Broker Non-Votes.
- Proposal 2: Ratification of Independent Registered Public Accounting Firm. Stockholders ratified the appointment of PricewaterhouseCoopers LLP for the fiscal year ending December 31, 2022.
- Voting Results: 22,756,875 votes For; 1,498 votes Against; 2,521 votes Abstain; 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. No forward-looking statements or risk disclosures were included in this specific report.
Key Facts for Investor Verification
- Confirmation that Michael Favet and Frank Fischer were successfully elected to the Board of Directors.
- Verification that PricewaterhouseCoopers LLP was ratified as the independent auditor for the 2022 fiscal year.
- Review of the significant number of Broker Non-Votes (6,497,979) recorded for the director elections.